Literature DB >> 10901785

[Evaluation of inpatient satisfaction. Comparison of different survey methods].

J Labarère1, P François, D Bertrand, M Fourny, F Olive, J C Peyrin.   

Abstract

OBJECTIVES: To assess the impact of patient satisfaction survey method on response rate, data quality and satisfaction. PATIENTS AND METHODS: Four modes of data collection were assessed during a randomized trial that included 400 inpatients discharged from a teaching hospital.
RESULTS: The response rate was 58% within the mail survey group (72% with follow-up letter) versus 73% and 81% within the home and telephone interview group (p < 0.01). 69% of the mailed questionnaires contained no missing values versus 94% and 96% for home and telephone interview modes (p < 0.01). The global satisfaction scale score was greater within the mail survey groups (8.1/10 without follow-up letter and 7.9 with follow-up letter) than within the telephone interview group (7.8) and the face to face interview group (7.3), (p < 0.05).
CONCLUSION: Mail survey with follow-up letter constitutes an operational method despite lower data quality and overestimation of patients' satisfaction scores.

Entities:  

Mesh:

Year:  2000        PMID: 10901785

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

Review 1.  Methods to increase response to postal and electronic questionnaires.

Authors:  Philip James Edwards; Ian Roberts; Mike J Clarke; Carolyn Diguiseppi; Reinhard Wentz; Irene Kwan; Rachel Cooper; Lambert M Felix; Sarah Pratap
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

2.  Patients' satisfaction and opinions of their experiences during admission in a tertiary care hospital in Pakistan - a cross sectional study.

Authors:  Sardar Zakariya Imam; Khezar Shahzada Syed; Syed Ahad Ali; Syed Umer Ali; Kiran Fatima; Marium Gill; Muhammad Ovais Hassan; Saad Hasan Hashmi; Maham T Siddiqi; Hadi Muhammad Khan; Omar Farooq Jameel
Journal:  BMC Health Serv Res       Date:  2007-10-03       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.